Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03761160 · ClinicalTrials.gov registry record · NA
Mobile Health App to Mitigate the Metabolic Effects of Androgen Deprivation Therapy
A NA study, sponsored by Dana-Farber Cancer Institute.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT03761160 is a NA study that has completed, run by Dana-Farber Cancer Institute. The registered enrollment target is 10 participants.
The verdict
NCT03761160, a NA study, has completed, sponsored by Dana-Farber Cancer Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
This research study seeks to develop and evaluate a mobile health app which aims to provide patients who are about to initiate androgen deprivation therapy for prostate cancer with an exercise program and better eating habits.
Interventions
- OTHER Usual care
- OTHER Mobile Health App
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2019-07-16 |
| Est. Completion | 2020-07-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03761160
The ClinicalTrials.gov registry entry for NCT03761160 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dana-Farber Cancer Institute, which has 781 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Usual care is the first listed.
NCT03761160 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03761160 about?
NCT03761160 is a clinical study titled "Mobile Health App to Mitigate the Metabolic Effects of Androgen Deprivation Therapy". This research study seeks to develop and evaluate a mobile health app which aims to provide patients who are about to initiate androgen deprivation therapy for prostate cancer with an exercise program and better eating habits.
What is the current status of trial NCT03761160?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2019-07-16. Estimated completion is 2020-07-10.
What interventions are being tested in trial NCT03761160?
The interventions under investigation include: Usual care (OTHER), Mobile Health App (OTHER).
Who is sponsoring clinical trial NCT03761160?
This trial is sponsored by Dana-Farber Cancer Institute, which has 781 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.